Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-05-30 4:05 pm Purchase | 13D | TNF PHARMACEUTICALS, INC TNFA | PharmaCyte Biotech Inc. PMCB | 11,563,878 83.400% | 11,563,878 (New Position) | View |
| 2024-02-14 3:13 pm Purchase | 13G | TNF PHARMACEUTICALS, INC TNFA | Global X Management CO LLC | 3,108,473 6.110% | 3,108,473 (New Position) | View |
| 2024-02-14 11:27 am Purchase | 13G | TNF PHARMACEUTICALS, INC TNFA | Iroquois Capital Management LLC | 5,065,582 4.990% | 3,294,438 (+186.01%) | View |
| 2023-02-14 07:40 am Sale | 13G | TNF PHARMACEUTICALS, INC TNFA | Iroquois Capital Management LLC | 1,771,144 6.470% | -407,464 (-18.70%) | View |
| 2022-09-08 4:22 pm Purchase | 13D | TNF PHARMACEUTICALS, INC TNFA | DUFFEY SAMUEL S | 2,241,812 5.860% | 2,241,812 (New Position) | View |
| 2022-02-23 4:45 pm Purchase | 13G | TNF PHARMACEUTICALS, INC TNFA | Iroquois Capital Management LLC | 2,178,608 9.560% | 2,178,608 (New Position) | View |
| 2022-02-11 07:17 am Purchase | 13G | TNF PHARMACEUTICALS, INC TNFA | INTRACOASTAL CAPITAL LLC | 364,963 1.000% | 364,963 (New Position) | View |
| 2022-01-11 4:30 pm Unchanged | 13G | TNF PHARMACEUTICALS, INC TNFA | MAINFIELD ENTERPRISES INC | 0 0.000% | 0 (Unchanged) | View |
| 2021-04-26 6:29 pm Purchase | 13D | TNF PHARMACEUTICALS, INC TNFA | Williams Caroline C | 5,020,181 13.160% | 5,020,181 (New Position) | View |
| 2021-02-22 09:56 am Purchase | 13G | TNF PHARMACEUTICALS, INC TNFA | Iroquois Capital Management LLC | 3,121,620 9.990% | 1,026,072 (+48.96%) | View |
| 2021-02-18 2:22 pm Purchase | 13G | TNF PHARMACEUTICALS, INC TNFA | MAINFIELD ENTERPRISES INC | 1,081,081 5.800% | 1,081,081 (New Position) | View |
| 2021-01-29 06:31 am Sale | 13G | TNF PHARMACEUTICALS, INC TNFA | INTRACOASTAL CAPITAL LLC | 1,459,458 7.500% | -17,673,402 (-92.37%) | View |
| 2020-11-20 4:06 pm Purchase | 13G | TNF PHARMACEUTICALS, INC TNFA | INTRACOASTAL CAPITAL LLC | 1,459,458 7.500% | 1,459,263 (+748340.00%) | View |
| 2020-11-19 08:16 am Purchase | 13G | TNF PHARMACEUTICALS, INC TNFA | Iroquois Capital Management LLC | 2,095,548 9.990% | 2,095,548 (New Position) | View |
| 2020-05-26 06:23 am Unchanged | 13G | TNF PHARMACEUTICALS, INC TNFA | INTRACOASTAL CAPITAL LLC | 195 0.003% | 0 (Unchanged) | View |
| 2020-05-05 2:15 pm Sale | 13G | TNF PHARMACEUTICALS, INC TNFA | Hudson Bay Capital Management LP | 1,885 0.040% | -267,358 (-99.30%) | View |
| 2020-04-20 11:47 am Purchase | 13G | TNF PHARMACEUTICALS, INC TNFA | ALPHA CAPITAL ANSTALT | 200,000 4.205% | 86,430 (+76.10%) | View |
| 2020-04-17 4:15 pm Sale | 13G | TNF PHARMACEUTICALS, INC TNFA | INTRACOASTAL CAPITAL LLC | 195 0.010% | -58,700 (-99.67%) | View |
| 2020-01-09 3:53 pm Purchase | 13G | TNF PHARMACEUTICALS, INC TNFA | Hudson Bay Capital Management LP | 269,243 15.670% | 269,243 (New Position) | View |
| 2019-12-19 4:40 pm Purchase | 13G | TNF PHARMACEUTICALS, INC TNFA | INTRACOASTAL CAPITAL LLC | 58,895 4.990% | 58,895 (New Position) | View |